Get the Stockscreener App
4.61
13.99%
-0.75
After Hours:
4.45
-0.16
-3.47%
Icecure Medical Ltd stock is traded at $4.61, with a volume of 1.73M.
It is down -13.99% in the last 24 hours and up +5.61% over the past month.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
See More
Previous Close:
$5.36
Open:
$5.09
24h Volume:
1.73M
Relative Volume:
0.57
Market Cap:
$15.80M
Revenue:
$3.57M
Net Income/Loss:
$-15.74M
P/E Ratio:
-0.6635
EPS:
-6.9481
Net Cash Flow:
$-15.77M
1W Performance:
-12.36%
1M Performance:
+5.61%
6M Performance:
-76.94%
1Y Performance:
-85.43%
1-Day Range:
$4.51
$5.10
1-Week Range:
$4.51
$5.57
52-Week Range:
$2.12
$42.00
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
4.61 | 16.65M | 3.57M | -15.74M | -15.77M | -6.9481 |
ABT
Abbott Laboratories
|
95.63 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
324.73 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.06 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.60 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
95.18 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd Stock (ICCM) Latest News
IceCure Medical Ltd. Actuals & Estimates (NASDAQ:ICCM) - TradingView
IceCure regains compliance with NASDAQ - MSN
IceCure regains compliance with Nasdaq MBP requirement - Medical Buyer
Why Is IceCure (NASDAQ:ICCM) Catching Small-Cap Attention? - Kalkine Media
IceCure Medical Ltd. Actuals & Estimates (BOATS:ICCM) - TradingView
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC FilingForm 6-K - Stock Titan
What's Going On With IceCure Medical Stock On Friday? - Benzinga
IceCure Medical Regains Nasdaq Compliance on Minimum Bid Price - The Globe and Mail
Why Has IceCure Medical's Stock Price Collapsed - Kavout | AI
Icecure Medical(ICCM) Stock Options Chain | Quotes & News - Moomoo
IceCure Medical Files to Register Sale of 5.5 Million Shares by Armistice - marketscreener.com
ICCM: Selling Stockholders Plan to Offer 5.5 Million Shares - GuruFocus
IceCure Medical (ICCM) registers 5.5M shares tied to June 2026 warrants - Stock Titan
ICCM Forecast — Price Target — Prediction for 2027 - TradingView
IceCure Medical Ltd (ICCM) stock price, news, quote and history - Yahoo Finance Australia
IceCure Medical (Nasdaq: ICCM) back in compliance with bid price rule - Stock Titan
IceCure clears Nasdaq bid-price warning after 10-day run - Stock Titan
IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement - Barchart.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
$Icecure Medical (ICCM.US)$ - Moomoo
$Icecure Medical (ICCM.US)$ enough too 🫰🏽 - Moomoo
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer - Sahm
Icecure Medical | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16] - Moomoo
ICCM Stock Soars As ProSense Adoption And Funding Fuel Momentum - StocksToTrade
ICCM Stock Soars As ProSense Adoption And Funding Spark Momentum - timothysykes.com
IceCure Medical (ICCM) prices $5.5M private placement with warrant package - Stock Titan
IceCure Medical gains after ProSense update, $5.5M placement - TechStock²
Tumour freezing specialist IceCure Medical skyrockets from latest successes - Mugglehead Investment Magazine
IceCure announces pricing of private placement - Medical Buyer
Icecure Medical Ltd (ICCM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Icecure Medical Ltd (ICCM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Icecure Medical Ltd (ICCM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Icecure Medical Ltd (ICCM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Icecure Medical Ltd (ICCM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Icecure Medical Ltd (ICCM) Institutional Confidence - TradingKey
Icecure Medical Ltd (ICCM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Icecure Medical Ltd (ICCM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Icecure Medical Ltd (ICCM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ICCM Stock Price, Quote & Chart - ChartMill
BIRD, NBIS, ICCM, HOOD, META: 5 Trending Stocks TodayRobinhood Markets (NASDAQ:HOOD) - Benzinga
IceCure Medical Ltd announced that it has received $5.499819 million in funding - marketscreener.com
IceCure Announces Pricing of $5.5 Million Private Placement Pric - GuruFocus
IceCure Medical (ICCM) Sees Significant Growth in ProSense Insta - GuruFocus
IceCure Reports 70% Growth in Active U.S. Commercial Install Bas - GuruFocus
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor - PR Newswire
IceCure Medical (ICCM) Sees 70% Surge in Cryoablation Install Ba - GuruFocus
IceCure Stock Surges After 70% ProSense Install Increase - Benzinga
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally? - TradingView
Stock Gains on News of 70% Surge in U.S. ProSense Install Base Fuels IceCure's (NASDAQ: ICCM) Breast Cancer Treatment Momentum - Investorideas.com
IceCure Medical jumps on U.S. ProSense install base growth after FDA clearance - TechStock²
IceCure Medical surges after update on U.S. ProSense adoption following FDA breast-cancer authorization - Quiver Quantitative
Icecure Medical Ltd Stock (ICCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.62%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):